CREBBP mutations further disrupt the downstream components of the NOTCH pathway, leading to expression of CCL2 and CSF1, which in turn promote the polarization of tumor-associated macrophages toward the immunosuppressive M2 phenotype [56]. This evidence concerns the gene CREBBP and neoplasm.